Malaysia Swaps On-Site GMP Checks For Virtual Inspections At Foreign Sites
Executive Summary
The COVID-19 pandemic has driven the Malaysian National Pharmaceutical Regulatory Agency to explore new mechanisms to oversee compliance with good manufacturing practice requirements at foreign and domestic sites.